Elvitegravir, cobicistat, emtricitabine tenofovir disoproxil

Red

Brand Name(s):Stribild

Indication:HIV-1 infection in adults aged 18 years and over who are antiretroviral treatment naive or are infected with HIV-1 without known mutations associated with resistance to any of the three antiretroviral agents in Stribild

Rationale:1,2

Considered:Jul-13

Review Date:Apr-24

Comments:
Drug Safety Update
Elvitegravir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1
April 2019